Concord Medical Files 2024 Annual Report with U.S. SEC

April 26, 2025 | 11:11

(0) user say

The healthcare network discloses financials and strategic updates in its latest Form 20-F submission.

BEIJING, April 26, 2025 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 (the "Annual Report") with the U.S. Securities and Exchange Commission. An electronic copy of the Annual Report can be accessed on Concord Medical's investor relations website at http://ir.ccm.cn and on the SEC's website at www.sec.gov. Shareholders may receive a hard copy of the audited financial statements free of charge upon request.

Requests should be submitted to http://ir.ccm.cn.

By PR Newswire

Concord Medical Services Holdings Limited

What the stars mean:

★ Poor ★ ★ Promising ★★★ Good ★★★★ Very good ★★★★★ Exceptional